Louisiana MPJE Exam Prep

Enrollment open: 1,500 original practice questions built on NABP’s official MPJE Competency Statements. Enroll today and start with the free sample exam.

The Louisiana MPJE — the Multistate Pharmacy Jurisprudence Examination as administered for Louisiana licensure — tests federal pharmacy law and Louisiana pharmacy law in a single sitting, with no distinction between them: where the Louisiana rule and the federal rule differ, the Louisiana rule is the one the question is answered under. PassProfessor’s Louisiana MPJE program prepares you with 1,500 original practice questions built exactly that way — an 800-question federal core intermixed with 700 Louisiana-specific questions grounded in the Louisiana Pharmacy Practice Act, the Board of Pharmacy regulations, the Uniform Controlled Dangerous Substances Law and its Prescription Monitoring Program, and the state’s consent-based product selection rule — weighted to NABP’s current Competency Statements.

What the program covers

Every competency area on NABP’s current MPJE Competency Statements is covered at its published weight. The bank’s question count in each area, and what a full practice exam draws from each:

  • Licensure and Personnel — 333 practice questions; 22 per full practice exam
  • Pharmacist Practice — 498 practice questions; 33 per full practice exam
  • Dispensing Requirements — 358 practice questions; 24 per full practice exam
  • Pharmacy Operations — 311 practice questions; 21 per full practice exam

A full practice exam draws 100 scored questions — the scored length of the real exam — across all four competency areas at their published weights, inside a 150-minute limit that mirrors the real 2.5-hour clock. The real exam administers 120 questions: the same 100 scored questions plus 20 unscored pretest questions mixed in; this program’s draws are scored questions only. Practice exams are scored against a 70% practice benchmark: the real MPJE is pass/fail and NABP does not publish a raw passing score, so treat the benchmark as a practice target, not an NABP standard.

How the program works

Enroll once and the full course opens: full-length practice exams, a free 20-question sample to start with, and per-topic drills for focused work on the competency areas you want to strengthen. Every practice exam draws a fresh set of questions, so repeat attempts keep testing rather than repeating. Every question in the program includes an explanation of why the keyed answer is right.

Louisiana MPJE at a glance

  • Questions on the real exam: 120 administered (100 scored + 20 unscored pretest)
  • Time limit: 2.5 hours
  • Format: computer-based at Pearson VUE; federal and Louisiana questions intermixed, with no distinction between them
  • Scoring: pass/fail — NABP does not publish a raw passing score
  • Attempts: up to 5 per jurisdiction
  • Fees: about $270 per attempt in NABP fees
  • Eligibility: confirmed by NABP for Louisiana applicants
  • Score transfer: MPJE scores are not transferable between jurisdictions — a Louisiana pass applies to Louisiana licensure

The Louisiana law behind the exam

Half of what makes the Louisiana MPJE hard is that it is two bodies of law at once. The Louisiana half of this program is built on:

  • The Louisiana questions in this bank are grounded in primary Louisiana sources read first-hand: the Pharmacy Practice Act (Louisiana Revised Statutes Title 37, Chapter 14), the Board of Pharmacy regulations (Louisiana Administrative Code Title 46, Part LIII), the Uniform Controlled Dangerous Substances Law (Revised Statutes Title 40, Chapter 4) and the Prescription Monitoring Program Act (Title 40, Chapter 4, Part X-A), and the 2024 through 2026 session laws. Louisiana’s rulebook has moved recently: the controlled-substances chapter of the Board’s regulations was rewritten effective May 20, 2026, and the state-specific rules that used to sit in the older sections — prescription expirations, the annual controlled-substance inventory, theft-and-loss reporting — now live in a single section, LAC 46:LIII.2713. This bank keys on current law throughout, including the 2026 changes.
  • Louisiana’s prescription monitoring program is the PMP — and in Louisiana the familiar name trap does not fire, because the name is defined in the statute itself: ‘Prescription monitoring program’ and ‘PMP’ are defined terms at R.S. 40:1003(14), in the Prescription Monitoring Program Act (R.S. 40:1001–1014). The Act also defines ‘Board’ — it means the Louisiana Board of Pharmacy, which establishes and maintains the program. The Department of Health does not administer the PMP (it holds the separate authority to schedule substances), and the program’s software vendor is not its administrator. The reporting duty falls on the dispenser, and it is fast: no later than the next business day after dispensing, for Schedule II, III, IV and V controlled substances and for drugs of concern — the seven-day and weekly figures in older study materials are superseded law. Louisiana’s mandatory look-up duty is narrow and sits on the prescriber: before initially prescribing an opioid, and at least every 90 days during continuing opioid treatment, under R.S. 40:978(F)(1); no equivalent look-up mandate falls on the dispensing pharmacist. Gabapentin appears on the Board’s current list of drugs of concern reported to the program, even though it is not a scheduled drug in Louisiana. PMP data are confidential — knowingly obtaining, using or disclosing them unlawfully carries up to five years in prison or a $5,000 fine — and the program’s annual fee is capped at $25, leviable only if the legislature does not fully fund the program.
  • Louisiana’s controlled-substance rules split between two agencies and carry their own numbers. The CDS license is issued by the Board of Pharmacy — including to third-party logistics providers — while the authority to place substances in the schedules belongs to the secretary of the Department of Health; neither function belongs to the other agency. Louisiana’s schedule choices diverge from the federal list in both directions: carisoprodol is Schedule II in Louisiana though it is Schedule IV federally; kratom is Schedule I and fully banned; and mifepristone and misoprostol are Schedule IV controlled substances here though they are not federally controlled at all — while gabapentin is not scheduled anywhere in Louisiana law. Since the May 2026 rewrite, a Schedule II prescription expires 90 days after the date it was issued, Schedule III and IV prescriptions expire at six months, and Schedule V at one year. Opioid rules reward close reading: a first prescription for acute pain in an adult, and any opioid prescription for a minor, is capped at a seven-day supply under R.S. 40:978(G) — and Louisiana has no morphine-milligram-equivalent threshold anywhere in the statute, so MME caps borrowed from other states’ rules are traps, not law. Electronic prescribing of controlled substances is permitted in conformance with the federal rules; Louisiana imposes no state e-prescribing mandate of its own. And an opioid-derivative Schedule II or III prescription written by an out-of-state prescriber may be dispensed for no more than a ten-day supply, with no further dispensing for sixty days.
  • Substitution in Louisiana runs on patient consent, not on a formulary. There is no standalone substitution statute and no Louisiana state or negative formulary: interchange is governed by an unprofessional-conduct standard under which the pharmacist must inform the patient of the equivalent product and its approximate cost difference and obtain the patient’s consent. The Medicaid prescriber bar works the other way from most states — the prescriber handwrites ‘brand medically necessary’ or ‘brand necessary’ on the prescription. After dispensing an interchangeable biological product, the pharmacist must communicate the specific product dispensed to the prescriber no later than five business days after dispensing. Refill emergencies run on Louisiana numbers, not the familiar federal ones: an ordinary emergency refill may run to a thirty-day supply, and during a governor-declared emergency a pharmacist may dispense up to a ninety-day supply without prescriber authorization, a power that activates automatically with the declaration — no seventy-two-hour figure exists in either Louisiana rule. Pharmacists alone administer immunizations in Louisiana: influenza vaccine from age seven, and all other vaccines from age seventeen. Pseudoephedrine sales are capped at nine grams per thirty days, reported in real time to the central monitoring system administered by the Louisiana State Police.
  • The people rules run on their own calendars. The Board of Pharmacy has seventeen members — two licensed pharmacists from each of the state’s eight pharmacy districts plus one consumer representative serving at large — and pharmacist members serve six-year terms. Aspiring pharmacists complete 1,740 internship hours, at least 1,500 of them practical; licensure begins at age twenty-one; and examination scores expire one year after the examination. A pharmacist-in-charge needs one year of experience. Continuing education is fifteen hours a year, including at least three live hours — or twenty hours in total if the live hours are not completed. Pharmacist licenses and pharmacy permits expire December 31 each year, while pharmacy technician certificates expire June 30. Under Louisiana’s license-transfer rules, the MPJE-La must be passed before the NABP license-transfer application can be completed, and no practice-recency requirement attaches to transfer. And Louisiana law states no numeric passing score for its examinations: the standard is a passing score, as determined by the Board, on examinations administered by NABP.

What changes on March 1, 2027

  • From March 1, 2027, NABP replaces the MPJE Competency Statements with a new Content Outline — Pharmacy and Pharmacist Practice 30%, Medication Use Process 30%, Regulatory Authority and Legal Obligations 20%, Pharmacy Operations 20%.
  • Every question in this bank is dual-tagged to both blueprints, so this program’s practice exams re-weight to the new outline when the change takes effect — the questions you are practicing now stay the right questions.

Three things worth knowing

  • One scoring point to be clear about: the 70% figure used inside this program is a practice benchmark only. The real MPJE is pass/fail against a standard NABP does not publish as a raw score, and no percentage — ours or anyone else’s — is the MPJE passing standard.
  • One portability point: MPJE scores are not transferable. (Score transfer belongs to the separate uniform UMPJE, used in 13 other jurisdictions.) This program prepares you for the Louisiana MPJE specifically.
  • One scope point: the 800-question federal core is the same law every MPJE state tests, but the 700 Louisiana questions key on Louisiana law. If you later seek licensure in another MPJE state, you will need that state’s law exam preparation, not Louisiana’s.

For the detailed walk-through of the exam’s format, scoring and rules, read the Louisiana MPJE Exam Guide.